SuperworthCentury Therapeutics shares outstanding IPSC
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 205.8M
- On a year earlier
- +138.6%
- more shares
Century Therapeutics had 205.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 138.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 87.3M | +2% |
| FY2024 | 85.4M | −38% |
| FY2023 | 137M | +135% |
| FY2022 | 58.3M | +6% |
| FY2021 | 54.8M | +633% |
| FY2020 | 7.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 205.8M | +139% | |
| Q1 FY26 | 193.5M | +125% | |
| Q4 FY25 | 87.3M | +2% | |
| Q3 FY25 | 86.5M | +2% | |
| Q2 FY25 | 86.2M | +5% | |
| Q1 FY25 | 86.1M | +38% | |
| Q4 FY24 | 85.4M | −38% | |
| Q3 FY24 | 84.7M | +42% | |
| Q2 FY24 | 82.1M | +39% | |
| Q1 FY24 | 62.3M | +6% | |
| Q4 FY23 | 137M | +135% | |
| Q3 FY23 | 59.4M | +3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Century Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.